SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-024738
Filing Date
2024-08-06
Accepted
2024-08-06 09:28:05
Documents
16
Period of Report
2024-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K alim20240522_8k.htm   iXBRL 8-K 26907
2 EXHIBIT 99.1 ex_678684.htm EX-99.1 207046
7 alimlogo1.jpg GRAPHIC 6741
  Complete submission text file 0001437749-24-024738.txt   395931

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alim-20240806.xsd EX-101.SCH 3408
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alim-20240806_def.xml EX-101.DEF 11806
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE alim-20240806_lab.xml EX-101.LAB 15857
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alim-20240806_pre.xml EX-101.PRE 12021
18 EXTRACTED XBRL INSTANCE DOCUMENT alim20240522_8k_htm.xml XML 2959
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34703 | Film No.: 241177572
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)